ARCHIVES

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

This article is from The Cancer Letter archive.

Vol. 13 No. 15 | April 10, 1987

Download PDF Visit The Full Archive

Related Articles

NCI Bypass Budget An Underutilized Document and Ignored By MB; Deserves Attention Of Congress

January 20, 1989

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002

In Brief: Kennedy’s Oversight Hearings Will Include Cancer Program, Important To Act Renewal

January 26, 1979

In Brief: What’s In A Name? DRCCA Doesn’t Do It; O’Conor Says ICRDB Program Should Consider New Challenges

October 3, 1980

National Dialogue On Cancer, The Cancer Act, And Activism.

February 4, 2000

NCI Issues Alert On Stage 2/3 Rectal Cancer Therapy

March 22, 1991